Archean Chemical Industries Ltd.

Archean Chemical Industries Ltd.

439.50
INR
-4.15
(-0.94%)
7.99EPS
59.50P/E
59.98BMarket Cap
Feb 05Next Earn

Q3 FY2026 · Earnings Call TranscriptFebruary 6, 2026

Operator

Ladies and gentlemen, good day and welcome to Archean Chemical Industries Limited Q3 FY '26 earnings conference call. As a reminder, all participants' lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing star, then zero on your touch-tone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr. Ranjit Pendurthi, Executive Vice Chairman of Archean Chemical Industries Limited.

Thank you, and over to you, sir.

Ranjit Pendurthi

Thank you. Good morning, everyone.

A warm welcome to all of you joining our Q3 and nine-month FY '26 earnings call. Thank you for taking the time to be here with us today.

On this call, we are joined by Mr. Rampraveen Swaminathan, Managing Director, Mr.

Natarajan Ramamurthy, CFO, Mr. Rajiv Kumar, DGM Finance, and SGA team, our investor relations advisor.

First update is on the changes in the senior management team. Further, the board has appointed Mr.

Rampraveen Swaminathan as the Managing Director of the company. We would like to welcome him to the Archean team.

Rampraveen Swaminathan has over 28 years of experience in business leadership, operations, and strategic transformation across industrials, energy, and manufacturing sectors. He has led large-scale growth, technology-enabled transformations, and operational turnarounds across multiple geographies and industries.

He has most recently served as the MD and CEO of Mahindra Logistics Limited, where he repositioned the company as integrated technology-driven logistics provider and significantly scaled its revenues. Our colleague Mr.

Kannan has decided to move out of the company due to personal reasons. I would like to place on record our thanks and appreciation for Mr.

Kannan for his contributions to the company. Mr.

Kannan will continue to work closely with Ram and myself over the coming months as part of the leadership transition. We are at a very exciting phase in Archean Chemical's businesses across the range of businesses we operate.

To further lead this exciting phase of growth, Ram has agreed to come on board and lead the management. I will now hand over to Ram to provide an overview of the business performance.

Thank you.

Rampraveen Swaminathan

Good morning, everyone, and thanks, Ranjit. I am pretty excited to be joining the team as we focus on developing the organization and scaling up our businesses further in the future.

I am also looking forward to engaging with our investor community, including all of you on the call today, and taking your inputs and insights as well on this journey. I hope you all have had a chance to go through the financial results and the investor presentation, which is available on our website and the stock exchanges' websites.

I will provide a quick summary of the overall business performance and then hand it over to Natarajan for a quick financial summary, and then revert back for the Q&A and closing comments. Starting with just an overall market environment, over the last We have been working operating in a mixed market environment driven by some of the uncertainties of the past three to four quarters.

While there are early indications of improvement, we expect the rest of this year largely to be one of stabilization and the operating environment to normalize as we move forward. We are closely tracking developments across the proposed India-US and the India-EU FTAs, which could be a platform to create new opportunities for the Indian specialty chemicals exporters over the medium to long term.

The India-EU FTA and other regional trade agreements will provide long-term tailwinds for the sector, though it has short-term limited short-term impact on our operating segments. During this period, our focus continues to remain firmly on strengthening the fundamentals of the business, driving focus growth, accelerating operational excellence, deepening our customer partnerships, and capability building across the enterprise.

Continued focus and acceleration on this will ensure that we are well positioned to benefit from these initiatives and other macroeconomic drivers, which we believe continue to remain extremely positive for our company and the sector as a whole. Coming more specific to our own performance, as we have mentioned in prior earnings calls as well, the overall business performance in the first two quarters was challenging, with results impacted by multiple issues, including erratic monsoons, logistics disruptions in our area of operations, some technical issues in our plant operations, and lower crude prices, which kind of impacted rig activity and affected some of our end markets.

We have also seen a mixed environment on pricing, with continuing pressure on industrial salt prices, but favorable movements on bromine. On a positive side, in the quarter we just completed, I think price salt pricing was stable, and that's kind of an a good good trend as we look forward.

Increasing bromine prices also put pressure on margins in the derivative segment and demand for some of the downstream products. Despite these challenges, I think we were able to capitalize on some of the tailwinds and drive stronger momentum in the third quarter.

We saw a healthy demand in the industrial salt segment, which showed strong volume growth year-on-year and also year-on-year growth in derivatives, which partially offset weaknesses in other segments, most specifically the bromine the bromine business. On a consolidated business, the company has reported 11% year-on-year revenue growth for the nine-month period, and for Q3 specifically, our revenues on standalone operations grew by 12%, and consolidated operations grew by around 10%.

I'd say growth was limited for us in as much by operational factors as by the market, and I'll talk about them a little bit more as I cover segmental performance. Going into specific segments, and I'll start off with elemental bromine.

Demand for bromine continues to remain strong. During the first nine months, India was a net importer of bromine, with stable to positive trends globally as well as domestically in terms of demand.

Short-term pricing trends have also remained favorable, and we continue to have a very healthy order book and are seeing positive traction with our customers. We will also continue to see growing demand internally from our derivatives business, which is Acume.

Overall, I think we believe we remain very well positioned from a market perspective. From a demand side, we definitely think that volume growth is likely to continue to happen.

Our engagement with clients remains strong, and they continue to support us. Obviously, this year and next year, we expect bromine captive consumption from our captive operations to also drive further growth.

During the quarter, as in prior quarters, I think our performance remained constrained by operational challenges and disruptions. These did continue to Some of the challenges we had in Q2 did impact us in early Q3 as well.

We have launched several improvement projects, which we expect will help us get back to steady state in Q4, and then we'll further scale up operations in the upcoming in the coming quarters. For the quarter, elemental bromine contributed approximately 24% of standalone revenues, and for year-to-date, it has been approximately 29% of our consolidated revenues.

On industrial salt, during the quarter, we sold approximately 1.1 million tonnes of salt, kind of reverting back to our quarterly run rate of more than a million tonnes. The segment contributed nearly 70% of standalone revenue, and for the nine months, our volumes are now about 3 million tonnes, with demand remained being robust despite the moderation in prices.

Sequentially, Q-on-Q, pricing has remained stable, and we expect that to continue in the short term. We have a strong demand visibility and our long-term contracts with our customers continue to be in good shape.

We continue to expect to scale this business up with some seasonal uptick in Q4 and continuing kind of expansion of operations as well. On SOP, which I think just continues to extending from what we had covered in the last quarter, our pilot stage trials have been completed successfully.

During the quarter, we have worked towards progressing from pilot to plant-scale trials. The site is ready, and we are on the verge of commencing plant-scale trials and expect meaningful contributions from this business in the in FY '27, especially the latter half of FY '27.

As we stated As you have stated repeatedly, we continue to believe and have strong conviction that SOP has significant potential for the business in the long term. Our challenges in that business has been obviously around changes in feed stock given brine quality, and those are the technical changes we are making in the plant operating system now, which should, when once successful, will kind of position us well to start scaling up operations again.

On bromine derivatives, which is essentially in Acume, our operations are up and running. We're currently at around 30% to 40% utilization.

We have around 40 reactors, and month-on-month they change, but generally on 30% to 40% utilization. Global uncertainties and obviously lower crude oil prices have impacted rig activities, which has further impacted the oilfield chemical market demand.

On the supply side, price increases on bromine have also increased cost pressures. However, we are engaging with clients, availing certifications, and approval, right, and expect the volumes to start scaling up.

We continue to focus heavily on product development. We have around 15 new products in pipeline, which are at different stages in in terms of customer trials and completion, and this should help us, we believe, grow to around 50% to 60% utilization in the coming quarters.

We've in the past mentioned about the flame retardant bromine project, a quick update on that. We are at the project evaluation phase there, and we'll provide more detailed update on that as we make progress.

Current market environment is kind of mixed there, we are trying to evaluate the feasibility of of that business and how quickly we can scale that scale volumes up. Now moving on to our strategic initiatives, especially in what I call advanced material space broadly.

On the semiconductor side, during our the quarter, our semicon business initiative through SysChem continued to make strong progress. As you're all already aware, SysChem is among the 10 projects approved by Union Cabinet under the Indian Semiconductor Mission.

The finalization of the fiscal support agreement with the Indian Semiconductor Mission is currently underway and is expected to complete to be completed soon, which will then give further finalization to the overall funding framework. Execution on the ground has already begun.

The 25-acre site in Infovalley, Bhubaneswar, has been allotted, and we held a groundbreaking ceremony on that at the site in November 2025. Land leveling is complete, and we are right now undergoing through topographical survey and soil testing right before we start any construction activity.

Along this Along the same time, we're also kind of investing in developing our go-to-market strategy, finalizing our supply partners, including for fab design, EPC, and project execution. Overall, we believe the project is well positioned from a timing perspective.

We are on target right now in terms of our internal schedules, and from a medium- to long-term perspective, we continue to believe that this is very well positioned to not just enhance our own business, but also, I think, contribute meaningfully to India's emerging compound semiconductor ecosystem. All right.

We'll continue to share This is a This is a long-gestation project, we'll continue to share updates with all of you as we move to the next phase of execution. Our energy storage storage business, which is the other other strategic initiative we have, as we have invested in Offgrid Energy Labs, a zinc-bromide battery innovator, with a robust IP portfolio of over 50 patents and more across cathodes, anodes, and separators.

In May 2025, just to remind everyone, we successfully acquired 18.14%, but the remaining commitment expected to be completed over the coming period. The company, as in Offgrid Energy Labs, plans to set up a 10 MWh demo manufacturing facility in the UK.

The work has already started and is progressing well, with the R&D for the next-generation stationary energy solutions kind of underway. Again, this is an project we continue to keep you all updated of progress in the coming quarters.

Overall, if I can look at summarizing at high at a summary level, our business fundamentals remain strong and robust. Our marine chemicals portfolio is well positioned, with high product quality, strong customer acceptance, and continued focus on strengthening our cost position.

Year-to-date, we have had some challenges operationally due to some external factors and operational factors really in the bromine business and, of course, some external issues around pricing on the industrial salt side. We remain focused on recovering this in coming quarters.

Our long-term investments in advanced materials are on track, continue to position us well for the long term. I'll now hand over to Natarajan to provide a more detailed financial summary for the quarter and for the year-to-date, and then I'll come back for the Q&A and the wrap-up.

Natarajan?

Natarajan Ramamurthy

Yeah. Thank you, and a very good morning to all the participants on the call.

We are pleased to report a notable performance for the quarter gone by. To give a summary of Q3 and nine-month FY '26 on a standalone basis, first start with Q3 FY '26 performance.

Total income for Q3 FY '26 stood at 2,608.1 million, 2.4% increase on a year-on-year basis. We have shared the revenue and business mix in the investor presentation for better understanding.

Our business mix is as follows in Q3. Bromine contributed 23% of the total standalone revenue, and industrial salt contributed around 77%.

Sales volumes of the business are as follows: Volume sales of bromine for Q3 FY '26 stood at 2,403 tonnes. Volume sales of industrial salt Q3 FY '26 stood at 1.1 million tonnes.

EBITDA for the company stood at 698.6 million in Q3 FY '26, 25% decline on a year-on-year basis. EBITDA margin stood at nearly 27% for the quarter.

Increase in expenses were largely due to increase in logistics costs, new employees, and other overhead costs from the new units. Net profit of Q3 FY '26 stood at around 343 million.

Coming to nine months performance, total revenue for nine months stood at 7,840 million, 7.4% growth on a year-on-year basis. EBITDA stood at 2,416 million, 10.8% dip on a year-on-year basis.

Net profit is 1,246 million, 1.6% decline on a year-on-year basis. On a consolidated basis, Q3 and nine-month performance stood as: Total revenue Q3 FY '26 stood at 2,615 million, bromine derivative 142.1 million, EBITDA for the company 613.5 million, and the net profit 240 million.

Nine-month performance, total revenue 8,016.7 million, EBITDA 2,166 million, and net profit 931 million. With this, we conclude the speech and open the floor for Q&A.

Rampraveen Swaminathan

Thank you, Natarajan. We'll now open for Q&A and I'll request the moderator to kind of facilitate the session.

Operator

Thank you very much. We will now begin the question and answer session.

Anyone who wishes to ask a question may press star and one on their touch-tone telephone. If you wish to remove yourself from the question queue, you may press star and two.

Participants are requested to use handsets while asking a question, and you are also requested to limit your questions to two per participant. Ladies and gentlemen, we will wait for a moment while the question queue assembles.

The first question is from the line of Sanjesh Jain from ICICI Securities. Please go ahead.

Rampraveen Swaminathan

Good morning, Sanjesh. Good morning.

Good afternoon, Sanjesh.

Sanjesh Jain

Quickly, I got a couple of questions, but before that, just data keeping questions. Natarajan, sir, can you repeat the revenue for Acume for Q3, SOP, and volumes for both?

Natarajan Ramamurthy

Sure. 1 second.

Q3 only, correct?

Sanjesh Jain

Q3.

Natarajan Ramamurthy

Q3 total quantity is 799 metric tonnes and value is in 137 million.

Sanjesh Jain

137 million.

Natarajan Ramamurthy

For nine months ended?

Sanjesh Jain

No, for SOP? No, nine-month we got.

Natarajan Ramamurthy

SOP you want?

Sanjesh Jain

SOP volume and revenue.

Natarajan Ramamurthy

SOP Q3 is 1 second, huh? Q3 is 71 metric tonnes.

Value is

Sanjesh Jain

2. 751?

Okay.

Natarajan Ramamurthy

No, 71, 71, 71.

Sanjesh Jain

71 metric tonnes. Okay.

Value is?

Natarajan Ramamurthy

Value is 32 lakhs.

Sanjesh Jain

Okay, 0.32. Now coming to the questions, you mentioned in the initial remark that you are seeing pressure on the bromine derivative, but on the other side, if I look at the bromine prices, they have really shot up.

Now both really doesn't add up. If there is a pressure on the derivative, how can the elemental prices go up or Or there is some supply constraint which is driving this bromine prices?

How should we read this commentary in together?

Rampraveen Swaminathan

No, I think my comment was that obviously the increase in bromine prices obviously has brought cost pressures on our bromine derivatives business. What I mean by that, Sanjesh, obviously is that given the specific products we are making right now, and the way the contracts are, not all of the cost increases is something we are able to pass through to our clients.

Right? You're seeing this trend where obviously bromine prices are up, and very favorable for us if our volumes have been better on the bromine side, but that increase is also putting cost pressures on the elemental bromine business.

That's why you have seen in the Acume side we've had to enhance our product development efforts towards new products, and also we've seen some downtick in our revenues because we've had to kind of adjust volumes on some other products where we had a higher cost impact.

Sanjesh Jain

No, I got it. There are only three products which significantly take away the bromine volumes globally.

Now what we are telling is that the derivative pressure is specific to the Archean, not to the industry, right? Then

Rampraveen Swaminathan

It's specific more to our products. That's why I made that comment that currently our current product portfolio has a longer tail on that, which is why I mentioned we are in the process of accelerating the 15 products we have in the pipeline.

Sanjesh Jain

Very clear. Second on the bromine, last quarter we mentioned that we have a 10,000 metric tonne of backlog, the production really not keeping up.

Just wanted to understand how much of this backlog is with the lower pricing which may hurt us because we are not fulfilling that, and probably we may have to fulfill them in the future? Number two, that means the realization we will be in the catching-up game.

Number two, what really is happening on the production side? Can you help us understand when we say that technical problem, what we really mean by technical problem?

Rampraveen Swaminathan

All right. Let me answer the first question first.

I think we have much of the order intake we had is roughly at the same price. It is very much still there, Sanjesh.

I think the 10,000-tonne or 9,500-tonne backlog we had at the end of last quarter, we've obviously shipped approximately 2,500 tonnes of that. We have still around 6,500 tonnes in backlog.

We've not seen a significant amount of cancellations there. We are obviously reviewing by contracts our individual customers on what we can do to reprice those contracts.

If I had to give a simple headline message, I think there will be some carry over the next 1.5 quarters or so, but we hope to then reset to market pricing over the next couple of quarters. Right?

There'll be some carry in it. Don't have a more specific answer at this stage.

Happy to kind of revert back to you with a little bit more detail there, but that's just a headline view. On the operational side, I think what's really happened is and I think Ranjit and Kannan may have spoken about this a little bit last quarter's call, we've obviously had a fair amount of weather changes over the first six months.

Flooding and kind of weather changes have meant that the brine quality, which then kind of drives the feed stock quality, has changed in terms of composition. That has meant that we've had to make some changes in our brine field operations to kind of ensure that we are enhancing the feed stock quality.

We've also had to make some changes or improvements in the operation in the plant itself to be able to kind of manage a wider range of brine or input feed stock. We had a trailing effect of that.

Essentially, throughputs came down because of that last quarter as well, and we had a trailing effect of that in the first half of third quarter as well. We then obviously launched some improvement projects.

That also resulted in some time off because we had to kind of make changes in the system. We ended the quarter getting back on a positive trend.

That's why I mentioned that I believe that in the coming quarters, earlier rather than later, we should be able to get to a steady state. Steady state to remind you, in my mind, is kind of what we did last year.

Last couple of years, we've been at the 18,000-tonne kind of level. We want to get back there, and then, obviously, our goal is still near to medium term to try and get to the 25,000-tonne run rate.

Sanjesh Jain

Got it. We had a capacity of 42.

Why are we targeting only 25? There's a disconnect between the capacity we have and the production we are targeting.

Rajiv Kumar

Sanjesh, Rajiv here. Hi, Sanjesh.

See, as we have previously mentioned in our call, the capacity expansion will actually primarily happen between 25 and 42 in line with the capacity expansion in the derivative business.

Sanjesh Jain

Okay.

Rajiv Kumar

Yeah.

Sanjesh Jain

As we put up more derivative, only then we will be able to extract more bromine, or we will be extracting more bromine probably.

Rampraveen Swaminathan

Yeah. That's a headline.

That's overall.

Sanjesh Jain

Got it. No, but just want to understand on the derivative side, there's a sharp drop in the volume.

How do we plan to ramp it up, and I think we are lagging significantly in terms of what we thought we can do. I know the market condition, but help us understand how should we look at FY '27 for us?

Rampraveen Swaminathan

Yeah. I think so this answers the question more clearly.

See, we're right now on 35% to 40% 30% to 40% utilization. First, the plant is first target for us, Sanjesh, is to kind of get the utilization up.

The second thing I think is that, the product mix we have we have, essentially three to five products which are running most of the volume. Those are things which we would like to kind of move away from or change the mix from away from that.

That's the two big focuses right now is to get the right product mix, get the right level of penetration with account with customers. The potential is there, even though markets are a bit soft, I think the potential is there.

We have we ended we started the quarter with around five, six products in the pipeline. Q3 and as we speak right now, we've actually expanded products to around 15 products which are now in trials and going through kind of customer acceptation acceptance, validation, and so on.

That's kind of the focus is to kind of expand the product portfolio and repivot the portfolio, like we say, towards better yield kind of products for us. What does this translate into math?

I think for the '26-'27, as I mentioned earlier, we are trying to scale it up to around 60% to 70% utilization at a plant level. Of course, that will move day-to-day or week-to-week based on which reactors we operate, but just from an overall throughput perspective to get to that 60% to 70% level.

That's the product portfolio we have been working on, and I think you will see that step up, Q-on-Q. It will not have be a it won't be a it's not a one-time switch, but over the next couple of quarters, you should start seeing that scaling up.

Sanjesh Jain

No, that's great. Thanks for answering all those questions so patiently, and best of luck for the coming quarters.

Operator

Thank you. The next question is from the line of Vinay Nadkarni from Hathway Investments Private Limited.

Please go ahead.

Vinay Nadkarni

Yeah. Good afternoon.

I have just one basic, fundamental question. When I'm looking at your company for the last what, seven, eight quarters now, whether it is Oren Hydrocarbons, whether it is your bromine derivatives, whether it is bromine also or SOP, everything gets delayed as the quarters go by.

Every time there is some kind of a delay that is happening. Is there any management bandwidth issue that you have which is impacting this?

Rampraveen Swaminathan

Hemant, firstly, every company has challenges around management bandwidth to scale up operations. That would be an oversimplification of the issue.

I think there are very specific challenges we've had, right? Obviously, bromine, we've had a good run rate prior as I think we've been at 17,000, 18,000 tonnes.

We are looking at run rate of around 25, and then as you mentioned earlier, to do a kind of minor brownfield expansion to take it around target of 40,000. We've had the setbacks which we talked about earlier.

I think we have good bandwidth on the ground, which is why we've been able to make these changes within one quarter. Right?

It's a continuous process manufacturing plant, and we've been able to make changes, in fact, without any major shutdowns. Right?

Because we have fairly good bandwidth on the ground. Industrial salt volumes are growing, right?

In that part of the business, I think there are headwinds, but there's no challenge around bandwidth. Right?

The Idachem investment was projected saying that it will take us multiple quarters as we had got the assets out of NCLT. We had to make step-wise changes.

There were issues in terms of local ecosystem challenges and so on. It's not been that we don't have bandwidth, we don't have team working on it.

It's just, I think, the nature of the program which we had, and we always, I think, bore caution to the fact that given it's an NCLT asset buyout, it will be a staged recovery process and not an overnight kind of scale-up. Three plants are now operational, right?

These products actually have a long customer certification cycle. It's not a commodity product like salt, right?

Therefore, it does require a fair amount of customer approvals. Three plants are up and running now.

We are in the process of scaling it up. On the Acume side, in the derivative side, yes, I think that's a piece which has been I think we are to execute that a little bit better, and those are changes which we're making, right?

I think and a lot of that is around product development. We've accelerated that over the last quarter, and we continue to focus on accelerating that this quarter even further, right?

That's a piece where back-end is really solid. Right?

The plant's in great shape. It's very good.

It's got great operating metrics, but the demand side scale-up has been weak because we have had to kind of rework our go-to-market and our product portfolio. I take your point, and that's what we are working on right now.

Vinay Nadkarni

Yeah. My observation was also on SOP because that is one high-margin product that you have, and which has got a good demand also.

Somehow, quarter after quarter, we see delays getting a little too frustrating now.

Rampraveen Swaminathan

Vinay, our conviction on SOP still remains extremely strong. We've maintained that now for several years.

Right? It's a complex technical issue and it's not the lack of our resources committed to it or the capability of the resources.

We have strong resources, partnerships globally, but it is a complex technical problem which takes time to solve. I think we are now getting close to a point where we think we have, I would say, a more enduring fix.

We have been trying to do many short-term fixes, which obviously have not given the yield we're expected. We are now at a point where I think we have a more enduring fix, but it'll take us a few more quarters to get there.

Vinay Nadkarni

Thanks a lot for the answer. Looking forward to a brilliant FY '27.

Operator

Thank you. The next question is from the line of Rohit Nagraj from 360 ONE Capital.

Please go ahead.

Rohit Nagraj

Thanks for the opportunity. Good afternoon.

First question is in terms of the contracted volumes for bromine. If you can just help us understand how much is maybe a medium, long-term contract and how much is spot?

The perspective that we want to hear is whenever there is change in bromine prices, whether we'll get that advantage or not? Because I think last year also it happened sometimes in the month of April, May, bromine prices went up, but it was not reflected in our performance.

In the last couple of months, now bromine prices have gone up beyond $5,000. When we will be able to see the tangible benefit in the financials?

A broader perspective in terms of contracted spot will also help us.

Rampraveen Swaminathan

Yeah. I think I assume you were there in the earlier part of the call as well when I answered part of this in some ways.

I think we have around 6,500 tonnes of contracted backlog, right? That's not backlog which is only for one quarter, two quarters.

It's kind of spread over a period of time. We have a mix of both spot and contract prices.

We have, obviously, the balance of both long-term contracts and short-term contracts in the mix. I think the challenge for us is about the production side of it.

Obviously, when the production side has been trailing, we have not had enough bromine coming out to actually balance both those customer sets. We do have to make strategic calls given our customer relationships, and that's probably the reason why you may not have seen some of these impact, at least this year.

I can't talk about last year, but this year's perspective. I think as I mentioned, we'll probably see a trailing impact of some of these contracts for a couple of quarters.

The exact impact of it will also be a function of how much we're able to get through into our system, right, in terms of production. At this stage, that's probably the best input I can give you is that I do think we will see that the contracts will have a impact over the next couple of quarters, but the longer-term contracts should probably represent probably 50% to 60% of our volume and not more than that.

Okay?

Rohit Nagraj

Just a clarification on this. Once these long-term commitments are over, what could be the optimal mix in terms of maybe a medium, long-term contracts and spot, just to get an advantage of the spot market as and when [unclear], otherwise, yeah.

If you could just hold,

Rampraveen Swaminathan

let me come back to you specifically on that. I don't have a perfect answer on that right now.

Right? We're still kind of reviewing some of this as well, but somebody from our team will reach out to you separately outside this call.

Rohit Nagraj

Sure, sir. Thank you.

Sir, second question is in terms of next year, given the constraints that we have on bromine, is there a fair chance of reaching at least the 18,000 tonnes of production, which includes both the element sale as well as for our captives?

Rampraveen Swaminathan

Simple answer, yes. Right?

Rohit Nagraj

Perfect. That's helpful.

One more question I just want to squeeze in. Oren, we had indicated that there've been delays in terms of the revenues.

Next year, what is the reasonable number that we can put, 100 crores, 150 crores, based on the current understanding of where we are?

Rampraveen Swaminathan

See, I think as a matter of rule, we don't give guidance, but what I would say, I think, is on the Acume side, I was very specific. We do expect we'll get to a 50% to 60% capacity utilization there.

On the Oren side, the Idachem side, as I said, we are still in the process of scaling up plants and operations, at this stage, I'd probably defer answering that question, but if we can pick that thread on it next quarter, I'll probably be able to give you better insight on it.

Rohit Nagraj

Fair enough, sir. Thanks a lot for answering all the questions, and all the best, sir.

Okay.

Operator

Thank you. The next question is from the line of Aditya Khetan from SMIFS Institutional Equities.

Please go ahead.

Aditya Khetan

Yeah. Thank you, sir, for the opportunity.

Just a couple of questions. Sir, on the bromine side, today, climate change is quite visible as you mentioned like there was some bad weather impact.

It seems nowadays like even a smaller wind comes, it takes away our volumes. Sir, just putting things in perspective, how many months or days of lost volumes we can build?

What is the sustainability of the numbers which you have given of 25 kt? How should one put faith in the numbers like this bad weather impact wouldn't be there in the coming fiscal, one to two or one to two years?

How should this play out like in the longer run?

Rampraveen Swaminathan

No, I think the weather impact is two things, obviously. In some extreme cases, it can result in a total shutdown of operations.

The larger set of issues we've had is more about adapting our systems to it. When these changes happen, they obviously change the flow of feed stock and the chemical capabilities of the system.

I am reasonably confident that I think we have falls on most of this implemented now. There is clearly a road map to get to that 17.5, 18,000 number.

As I mentioned to Vinay earlier that, simple answer, we will be north of 18,000 tonnes next year. Right?

Now the goal is to get to a run rate of between 18 and 25,000, at which stage we'll obviously have to do some expansion work, right, and we're hoping that the derivatives bromine business will also start scaling up meaningfully at that stage, we can actually make that step-up beyond 25,000. Right?

I don't think this is a flash in the pan thing. Whenever it happens, we just end up going sideways.

There are technical things which one has to do to solve the problem, and that's what we have taken care of now. You should start seeing that coming through in our results as well.

Aditya Khetan

Got it, sir. Onto the bromine derivative side, we had clearly witnessed the business has not been able to ramp up quite steep.

Just, sir, want to know you mentioned earlier also the demand is not that great today. Is that also related to the higher bromine prices because the feed stock prices are higher, consequently, the TBBA and PT bromine synthesis prices are also higher, which is where you might not been able to pass on, or the demand itself in the global world that is muted today?

Rampraveen Swaminathan

Let me just state this overall, just several of you might be interested. I think medium- to long-term demand on the derivative side is pretty good.

Right? Short-term demand across categories is also fairly stable and improving.

Our challenge has been in scaling up the business has been in some of the specific products we make and driving penetration with the end-user accounts. Right?

That there is, obviously, there is a supply-side pressure, which we have to either optimize for our own cost of operations, or in different customer contracts pass it through to our clients as well. Right?

This is not that kind of a challenge. The steps we have taken, obviously, is to kind of refocus a lot on getting the right product portfolio out and increasing the speed at which we're getting products out.

Right? That's been the big pivot we have to accelerate in the business.

I think if we get the products expansion out and accelerated customer acceptance cycle, we should be able to get there. Obviously, we are, I think, probably 12 to 18 months behind.

I don't have exact number because I'm still trying to figure out some things, but I would say that whatever duration we are behind, a lot of this has just been how quickly we execute here. That's what I kind of commented earlier to the person who asked me, "Do I have a bandwidth issue?"

I think this is one area where we could have executed a little bit better, but we have put the fixes in now. We're putting some more fixes, we should be able to get this back on stream in FY '27.

I won't say that's going to happen in Q1 of FY '27, but from a run rate perspective, through the year, we should be able to get to that 60%-ish kind of capacity utilization.

Aditya Khetan

Got it, sir. Sir, just one last question.

Sir, considering the recent geopolitical tensions between Israel and Iran, while talking to customers, are they hinting about diversifying from Israel to India volumes because Israel Chemicals, which is the biggest player in Israel, if these things turn out, there could be some short-term supply chain issues, supply issues, and customers are looking more towards India, towards other players? Is there any sort of things you're talking in?

Secondly, sir, if you can also highlight the global supply. Is there any new player which is entering or existing players looking to expand the supply in China and in other countries?

That would be helpful.

Rampraveen Swaminathan

Yeah. I think some supply will come up globally probably next year or so with expansions probably in Australia, right, somewhere towards 2027 or so.

Right? Again, these are organic changes which do continue to happen.

From a demand perspective, I think our focused markets have actually been around Asia, South Asia and East Asia, and we've not heard any significant repivot. Demand still stays stable and growing, right, and therefore, I don't think anything to be concerned about in that sense.

No immediate upside as well because of the way global supply chains work, but in our kind of focused markets, we don't see anything dramatically changing. I think we've heard from our customers, at least.

Aditya Khetan

Got it, sir. Thank you.

Operator

Thank you. The next question is from the line of Dhruv Muchhal from HDFC AMC.

Please go ahead.

Dhruv Muchhal

Sir. Thank you so much.

Sir, one of the challenges in the bromine production, I believe, as you have mentioned in some of the previous calls, was also as you're focusing somewhat on the SOP. As you're confident of the recovery in bromine from next year, also can you highlight how the SOP trajectory could be?

I understand it's still on the plant trial stage, probably starting soon, but some early trends if you can share something on that.

Rampraveen Swaminathan

I think our pilot trials, these are fairly independent programs, obviously, and the pilot trials have been successful. The chemistry works.

We have been able to ensure that we are getting good yields out, and from a quality perspective, we are good. We have the plant-scale trials somewhere in this quarter or early next quarter.

We kind of got the plant ready. That's one of the reasons why probably volume has been lower in Q3 because we've been getting plant ready.

I think it's hard for me right now to give a specific number if that's what you're looking for. Okay?

I think once we finish the plant trials probably in April or May, we will be in a better sense to see what kind of ramp-up will be required. We'll have to understand what kind of modifications we have to do at a plant level.

We have an preliminary sense, obviously, of what has to be done, but we'll be able to confirm that only after we do the plant trials. That's when we'll be able to give a far clearer view on what the projected throughput will be.

You already know the capacity numbers, so that's been out there in the public domain for a long time. The goalpost is known to everyone, right?

We just have to come back with a more specific ramp-up plan, which we'll share with you as the plant trials get completed.

Dhruv Muchhal

Sure. Thank you.

The second

Rampraveen Swaminathan

I just want to highlight that obviously, we look at the FY '27 perspective, there will be plant modifications, etc., to be done. Once the plant trials are successful, we'll have to make some modifications of the plant.

Hard right now to say even what the FY '27 impact will be. A couple of you have asked that question, I just want to kind of briefly clarify that.

Dhruv Muchhal

Just to clarify, these plant trials will not have any implication on the bromine production because now that can

Rampraveen Swaminathan

No, no, nothing. They're independent value chains.

There's a lot of shared infrastructure on utilities and so on in the business, right, and on the feed stock side, but operationally, they are very different.

Dhruv Muchhal

All right. Sir, the second question was on the flame retardant project.

Now I think if I could have missed, but the project earlier, you had mentioned about 12 to 18 months for the project. I think in the commentary you mentioned earlier that you're relooking at the project now.

This was to be a downstream project, which could have taken some of the virgin bromine. Assuming this project is on hold for now, does it have any implications on how you ramp up your elemental bromine now?

Rampraveen Swaminathan

No, I think what I mentioned was that we are evaluating the project feasibility and not the viability, right? We are going to continue to work on flame retardant.

It's only that we are working through the project details and working on that. It has no direct impact on our ramp-up plan.

The 60% to 70% growth with the utilization I had talked about, right, that is something which we hope to achieve in either case.

Dhruv Muchhal

No. The near term happens for the, for example, FY '27 happens, FY '28 also happens because of your other downstream bromines.

Assuming this project, still not very clear. Is this project on hold or not on hold?

Rampraveen Swaminathan

No, it's not on hold. It's just that we are working on it in a fair amount of detail, trying to ensure that we launch the product properly, and that we have a clear ramp-up plan which we deliver on.

Right? Right.

As I said, and that's kind of what we're working on in a very detailed project plan. Like I talked about what we did in SysChem at a high level.

We talk about SysChem in more detail, but very similar approach here as well. We're trying to do the project planning in a lot more detailed way, ensure that we are fail-safing execution, looking at margins, returns, product mix, etc., a lot more carefully, and that's why the execution is taking a longer period of time.

It's not on the back burner. It's not off the burner.

It's very much on the burner.

Dhruv Muchhal

Okay. Because I was just looking at 2Q conference details.

You had earlier mentioned it can come online in 12 to 18 months. Assuming in 2Q, end of FY '27-ish somewhere.

Does that timeline still remains or that's changed?

Rampraveen Swaminathan

Yes, still remains.

Dhruv Muchhal

Okay. Got it.

Okay. Basically you're just reconfiguring the product mix and that way.

Okay.

Rampraveen Swaminathan

That is the update I gave, say, that we're working through the project details, and that's all it is. We'll be giving an update because we mentioned in Q2, that's why we gave an update this quarter.

Dhruv Muchhal

Got it. Perfect.

Great. Thank you so much, and all the best.

Thank you.

Operator

Thank you. The next question is from the line of Rushabh from RBS A Investment Managers LLP.

Please go ahead.

Rushabh Shah

Hi, sir. Thank you for the opportunity.

Just to get a more sense on the weather impact that we have over the years. You mentioned that we've done some fixes currently.

I just want to understand next time the bad weather hits us, does the impact remain as same as earlier or we're better off now?

Rampraveen Swaminathan

Bad weather is a very broad statement, but as I said, I think, what does bad weather do to us? I'm just going to repeat what I said earlier.

Bad weather can either have impact on just operating environment or it can just have an impact on the brine fields, and overflooding, etc., can change that. I think technically we will be in a strong position to manage those kind of challenges going forward, right?

If you have a cyclone or something which requires you to kind of temporarily take safety measures on operations, that's something which, I don't think any fix we can have that means we're to protect against that. On the feed stock, the brine fields, etc., and what higher levels of rain or floods, etc., do to that, those are things which I think we've put in the fixes to try and get strong process control and be able to manage that range of width.

Rushabh Shah

There's some more

Rampraveen Swaminathan

work to be done. Go ahead.

Rushabh Shah

Yeah. Given that we have so much on our plate right now, and I just want to understand on the senior management and the mid-senior management bandwidth, are we done with hiring?

What is the progress on that so that next time, as the industry tailwinds appear, we don't falter again. Just want to understand on that sense.

Is the team up and running?

Rampraveen Swaminathan

I think, let me give you a perspective of someone who's fairly new to the job, right? I obviously have a very sharp sense on this.

I think, organizationally, we are well set up. Right?

I'm not worried about it as well. We had to add some capacity as the business grows, but I would say that from a capability perspective, there are many pockets in the company where the capability is very deep.

Even some of the changes we made on the bromine operations, as I said, we've done it without any shutdowns, and we've done it within six to eight weeks in some of the changes we've made. Those are a reflection of the depth we have technically and on the execution side.

I wouldn't be worried about that in that sense. I think we've got plans around it, and we are executing for sure.

Rushabh Shah

Just the last question to Mr. Ranjit.

Post the designation change, where will we devote your time more now? If we just share your thought process now and then.

Ranjit Pendurthi

I think I'm happy that the management depth is increasing. I think that's one of our tasks as promoters to ensure that there are people who are right and fit for the job to be able to take it up, and then move the company at the speed and execution level that we want.

I think that's the first change that we have consciously made. With your specific question regarding my own role, I think it will remain strategic.

I think that's where possibly most of my time will go. We do have the new initiatives going on.

While I work with Ram on the existing business and making sure that I'm an enabler for him, and guiding and helping him make these things happen in the existing base businesses, I think my focus will also possibly more shift towards strategic initiatives in making the semiconductor business happen on the ground, team building there, and working on that part of the business as well.

Rushabh Shah

That sounds great, sir. Thank you, sir.

Wish you all the best.

Ranjit Pendurthi

Thank you.

Operator

Thank you. The next question is from the line of Rikin Shah from The Boring AMC.

Please go ahead.

Rikin Shah

Hi. Thank you for taking my question.

I just wanted to ask on the Oren side. In Q4 FY '25, we have guided for 150, 160 crores revenue in FY '26.

In Q2 FY '26, we have guided that nothing will meaningfully come this year, and we've shifted the guidance to FY '27. We had acquired this asset through NCLT.

It was well known to have complexities. Why was the initial diligence so far off regarding regulatory timelines and other challenges?

Now that you're guiding numbers to come in FY '27, what is giving you reasonable confidence that this will happen?

Rampraveen Swaminathan

I think the first thing on this from a diligence perspective, we did a diligence in operating assets, the products which we can make from there, and obviously, what would be a reasonable operational time to get the assets back. As always coming out of an NCLT process, there are several other issues we have to deal with as well.

I'm being in the ecosystem factors which are dealt with, your local local environment issues, local communities and we have to engage with, labor groups which we have to engage with. That is something which So, our ability in each in any scenario to to predict the last part of it perfectly is a is a challenge.

Right? I think the first two parts, which is getting the plant readiness back, understanding go-to-market and products, I think those we are being fairly fairly in good shape, even in terms of what we projected.

The plants were shut down for nearly six years, and we have we forecast to be aggressively we'll be to get plants back in a year. We've got three plants up in 12 months, right, in fact, even lesser if you actually see the actual operating days we had.

We've had obviously challenges which you had to deal with, right, and they do and therefore, it's been on-off, on-off situation. Now that the plants are So, that's been the real issue, right, what we could predict, the things which you can control, which can influence, which are not some which are out of our control.

That's been the factors which has been here. Nobody wants us we obviously want to we bought the asset, we want to ramp it up quickly, we put in resources to kind of scale that up.

We want to always work on it in the hardest way possible. What gives us confidence now is obviously our plants are up.

Three of the plants are up. We are operationally there.

We are getting the customer trials are going on in different products. We are in the process of ramping it up, and and I think just the fact that we have operational stability now is what gives me the most confidence.

Right? That we will start seeing scale-up.

I don't I I think I this stage I'm not going to give you a number saying, 150, 160 crores, etc., but I think you will start seeing meaningful progress in terms of getting this up and going. That's been the real challenge which has been there.

Rikin Shah

Okay. Got it.

Even in SOP, we are seeing similar patterns, that in Q1 FY '26, we have stated meaningful contribution. In that previous in the last quarter, Q2, we have stated that trials will only happen after Q4 and production will start post-monsoon next year in FY '27.

We are seeing persistent delays in other segments. Are there some issues fundamentally?

You have obviously clarified on bandwidth issue that you are saying that they don't exist, but just trying to understand why these delays are happening and in all these segments.

Rampraveen Swaminathan

I think, Rikin, it's a fair point. In one way, obviously, from outside-in view, several of our programs have got delayed.

I'm going to take that on as a matter of fact because they are a matter of facts. I think, clearly, what I think is the one thing which we can do a lot better on is our ability to see the interplay between external and internal factors, and organize ourselves better to respond to them.

Right? That's the piece which we are investing a lot more on doing right now.

If you look at the SOP issue, I think there have been technical delays. We are working with a technology partner there.

Pilot trials do take time. I won't say it's hit and miss, but there are multiple scenarios which they test on, and it's a bit iterative because you get results in every trial and try to rework it.

We went into FY '25, '26 thinking that we're in a good shape there, but obviously, as we did the trials, we gave you an update that we will actually require more time on it. I think Idachem is a very unique case because of the NCLT issue, right?

These two are, in my mind, are two big things which, as you called out, probably have been more longer-term shifts. One is very technical, and the other one, I think, is a bit of an ecosystem issue.

Can we do a better job of synchronizing between external and internal factors? I think, definitely, and that's our job as a management team to execute better.

Hopefully, you will see that going forward.

Rikin Shah

All right. Sure.

Lastly, just building up on what

Operator

Mr. Shah, sorry to interrupt you.

Can you please rejoin the queue for more questions?

Rikin Shah

All right. Sure.

Operator

Thank you. The next question is from the line of Rohit Sinha from Sunidhi Securities.

Please go ahead.

Rohit Sinha

Yeah. Thanks for taking my question.

Most of my questions are already answered. Just one thing on the order backlog which we are seeing around 6,500 for derivative side.

Obviously, Yeah, for

Rampraveen Swaminathan

bromine. For bromine.

That was a comment on bromine, not derivatives.

Rohit Sinha

Okay. For that 6,500 is pertaining to which geography or industry, if you can indicate?

Rampraveen Swaminathan

I think it's across the board. There's no specific factor of materiality in that.

It's across the board. The only thing I would say that it's not 6,500 tonnes which is all due.

No, our contracts are stand for different delivery dates. It's not necessarily that the all 6,500 are actually all to be dispatched today.

They are to be dispatched over a longer period of time, right, and that's why we have a balance between short-term contracts and long-term contracts in the portfolio. As the volume starts getting ramped up, you will start seeing that getting kind of burnt out.

Right? Or it's getting repriced.

There's no specific trend line which has shifted in that. Largely, we remain a lot heavily focused on the Asian markets for the larger part, and our segments still remain pretty much the same, no real shift.

Rohit Sinha

Okay. Okay.

In industry-specific, if you can indicate?

Rampraveen Swaminathan

Sorry?

Rohit Sinha

For which industry these products are already indicated for the region-wise as Asia-Pacific mainly will be having this, but on the industry side, whom we are going to supply this on volume?

Rampraveen Swaminathan

If you can just send an email to SG. Probably I am not able to understand the question very well, but if you can just send in a deep query to our investor relations team, we will give you a more detailed response on it.

I will share whatever is not very sensitive, but please let us know. Okay?

Rohit Sinha

Okay. One just for information sake for this semiconductor side, if you can just indicate the timeline from where this financial agreement will be completed, and post how things will be progressing, and by when we should start seeing the final output from the plants?

Rampraveen Swaminathan

I think as I mentioned earlier, one is on the ground. I think we broke in ground.

We're going through topographical evaluation, soil evaluations, and so on. That is one item which is going on.

I think the funding framework has to be finalized. That's something which we're having discussions with the Indian Semicon Mission on.

That's an external dependency, which we don't have a clear end date on, right? We have in good shape there.

We have got good progress happening there. Once that gets finalized, I think we'll be in a position to give you more specific details on timing and impact.

Rohit Sinha

Okay. Fair enough.

That is from my side, sir. Thank you.

Rampraveen Swaminathan

Thank you.

Operator

Thank you. Ladies and gentlemen, in the interest of time, that was the last question.

I would now like to hand the conference over to the management for the closing comments.

Rampraveen Swaminathan

All right. Thank you all for joining us in the call today.

We appreciate your time and continuing interest in the company. In case of any queries, you may, please, feel to get in touch with SGA, our investor relations advisor, and obviously, I look forward to meeting all over the next call and some of you probably even before that.

Thank you all for your interest and participation.

Operator

On behalf of Archean Chemical Industries Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.